Pmv Pharmaceuticals Stock Price on November 25, 2024
| PMVP Stock | USD 1.60 0.01 0.63% |
Below is the normalized historical share price chart for Pmv Pharmaceuticals extending back to September 25, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Pmv Pharmaceuticals stands at 1.60, as last reported on the 29th of November, with the highest price reaching 1.64 and the lowest price hitting 1.59 during the day.
If you're considering investing in Pmv Stock, it is important to understand the factors that can impact its price. Currently, Pmv Pharmaceuticals is very risky. Pmv Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.02, which implies the firm had a 0.02% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Pmv Pharmaceuticals, which you can use to evaluate the volatility of the company. Please check Pmv Pharmaceuticals' Coefficient Of Variation of 5101.98, risk adjusted performance of 0.0218, and Semi Deviation of 1.99 to confirm if the risk estimate we provide is consistent with the expected return of 0.0486%.
At this time, Pmv Pharmaceuticals' Liabilities And Stockholders Equity is relatively stable compared to the past year. As of 11/29/2024, Stock Based Compensation is likely to grow to about 13 M, while Other Stockholder Equity is likely to drop slightly above 362.5 M. . At this time, Pmv Pharmaceuticals' Price Book Value Ratio is relatively stable compared to the past year. As of 11/29/2024, Price Earnings To Growth Ratio is likely to grow to 0.21, while Price To Free Cash Flows Ratio is likely to drop (2.76). Pmv Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 25th of September 2020 | 200 Day MA 1.6637 | 50 Day MA 1.5812 | Beta 1.484 |
Pmv |
Sharpe Ratio = 0.02
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PMVP |
Estimated Market Risk
| 2.43 actual daily | 21 79% of assets are more volatile |
Expected Return
| 0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Pmv Pharmaceuticals is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pmv Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 0.4184 | Book Value 3.824 | Enterprise Value -86.8 M | Enterprise Value Ebitda 1.2385 | Shares Float 41.5 M |
Related Headline
MediciNova Headline on 25th of November 2024
MNOV Monetary Damages Due Following SanofiNovartis Patent Di... by finance.yahoo.com
By David Bautz, PhD NASDAQMNOV READ THE FULL MNOV RESEARCH REPORT Business Update Monetary Damages Due from SanofiNovartis Litigation Settlement On November 11, 2024, MediciNova, Inc. announced a settlement in the patent litigation brought by Genzyme Corporation, a subsidiary of Sanofi, against Novartis. The litigation included a claim for infringement of U.S. Patent No.
Pmv Pharmaceuticals Valuation on November 25, 2024
It is possible to determine the worth of Pmv Pharmaceuticals on a given historical date. On November 25, 2024 Pmv was worth 1.62 at the beginning of the trading date compared to the closed value of 1.59. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Pmv Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Pmv Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Pmv Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Pmv Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 1.61 | 1.63 | 1.57 | 1.61 | 129,335 | |
11/25/2024 | 1.62 | 1.68 | 1.58 | 1.59 | 287,734 |
| 1.58 | 1.63 | 1.58 | 1.59 | 75,453 |
| Backtest Pmv Pharmaceuticals | | | Pmv Pharmaceuticals History | | | Pmv Pharmaceuticals Valuation | Previous | Next |
Pmv Pharmaceuticals Trading Date Momentum on November 25, 2024
| On November 26 2024 Pmv Pharmaceuticals was traded for 1.59 at the closing time. The top price for the day was 1.63 and the lowest listed price was 1.58 . The trading volume for the day was 75.5 K. The trading history from November 26, 2024 did not cause price change. The trading delta at closing time against the current closing price is 0.00% . |
Pmv Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Pmv Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Pmv Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Pmv financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Pmv Pharmaceuticals Stock history
Pmv Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Pmv is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Pmv Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Pmv Pharmaceuticals stock prices may prove useful in developing a viable investing in Pmv Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 48 M | 47.3 M | |
| Net Loss | -66 M | -69.3 M |
Pmv Pharmaceuticals Quarterly Net Working Capital |
|
Pmv Pharmaceuticals Stock Technical Analysis
Pmv Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Pmv Pharmaceuticals Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Pmv Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Pmv Pharmaceuticals November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Pmv Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pmv Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Pmv Pharmaceuticals stock market strength indicators, traders can identify Pmv Pharmaceuticals entry and exit signals to maximize returns
Pmv Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Pmv Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Pmv Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Pmv to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0218 | |||
| Jensen Alpha | (0.03) | |||
| Total Risk Alpha | (0.32) | |||
| Sortino Ratio | (0.03) | |||
| Treynor Ratio | 0.0667 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Pmv Stock Analysis
When running Pmv Pharmaceuticals' price analysis, check to measure Pmv Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pmv Pharmaceuticals is operating at the current time. Most of Pmv Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pmv Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pmv Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pmv Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.